Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder

被引:4
|
作者
Lv, Hui [1 ,2 ]
Gu, Xiao [3 ]
Shan, Xingyue [4 ]
Zhu, Tailin [1 ,2 ]
Ma, Bingke [4 ]
Zhang, Hao-Tian [5 ,6 ]
Bambini-Junior, Victorio [7 ]
Zhang, Tiantian
Li, Wei-Guang [8 ,9 ]
Gao, Xiaoling [3 ]
Li, Fei [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat & Child Primary Care, Xinhua Hosp,Sch Med, Brain & Behav Res Unit,Shanghai Inst Pediat Res, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Minist Educ,Sch Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Univ Collaborat Innovat Ctr Translat Med, Sch Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China
[4] East China Normal Univ, Minist Educ, Sch Life Sci, Shanghai Key Lab Brain Funct Genom, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Brain & Behav Res Unit,Shanghai Inst Pediat Res, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Minist Educ MOE,Sch Med, Shanghai, Peoples R China
[7] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England
[8] Fudan Univ, State Key Lab Med Neurobiol, Inst Translat Brain Res, Huashan Hosp,Dept Rehabil Med, Shanghai, Peoples R China
[9] Fudan Univ, Ctr Brain Sci, Minist Educ, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
autism spectrum disorder; bumetanide; nanoparticle; social behavior; microglia; MICROGLIAL ACTIVATION; MOUSE MODEL; BRAIN; EXCITATION/INHIBITION; NANOPARTICLES; INHIBITION; DELIVERY; CORTEX; NKCC1;
D O I
10.3389/fimmu.2022.870577
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with few medication options. Bumetanide, an FDA-approved diuretic, has been proposed as a viable candidate to treat core symptoms of ASD, however, neither the brain region related to its effect nor the cell-specific mechanism(s) is clear. The availability of nanoparticles provides a viable way to identify pharmacological mechanisms for use in ASD. Here, we found that treatment with bumetanide, in a systemic and medial prefrontal cortex (mPFC) region-specific way, attenuated social deficits in BTBR mice. Furthermore, using poly (ethylene glycol)-poly(l-lactide) (PEG-PLA) nanoparticles [NP(bumetanide)], we showed that the administration of NP(bumetanide) in a mPFC region-specific way also alleviated the social deficits of BTBR mice. Mechanistically, the behavioral effect of NP(bumetanide) was dependent on selective microglia-specific targeting in the mPFC. Pharmacological depletion of microglia significantly reduced the effect of nanoencapsulation and depletion of microglia alone did not improve the social deficits in BTBR mice. These findings suggest the potential therapeutic capabilities of nanotechnology for ASD, as well as the relevant link between bumetanide and immune cells.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Social and delay discounting in autism spectrum disorder
    Warnell, Katherine Rice
    Maniscalco, Sydney
    Baker, Sydney
    Yi, Richard
    Redcay, Elizabeth
    AUTISM RESEARCH, 2019, 12 (06) : 870 - 877
  • [42] SOCIAL INFORMATION PROCESSING IN AUTISM SPECTRUM DISORDER
    Back, Diana J.
    Francis, Sunday M.
    Skankland, Emma
    Wasserburg, Lucinda H.
    Jacob, Suma
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S100 - S101
  • [43] Social circuits and their dysfunction in autism spectrum disorder
    Sato M.
    Nakai N.
    Fujima S.
    Choe K.Y.
    Takumi T.
    Molecular Psychiatry, 2023, 28 (8) : 3194 - 3206
  • [44] Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder
    Staben, Jenika
    Koch, Megan
    Reid, Keelee
    Muckerheide, Jessica
    Gilman, Lauren
    McGuinness, Finn
    Kiesser, Sarina
    Oswald, Iain W. H.
    Koby, Kevin A.
    Martin, Thomas J.
    Kaplan, Joshua S.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [45] Premigration social adversity and autism spectrum disorder
    Augereau, Natacha
    Lagdas, Ines
    Kermarrec, Solenn
    Gicquel, Ludovic
    Martin, Virginie
    Xavier, Jean
    Cohen, David
    Bouvet, Michel
    Rolland, Anne-Catherine
    Tordjman, Sylvie
    BJPSYCH OPEN, 2020, 6 (05):
  • [46] Autism spectrum disorder model mice: Focus on copy number variation and epigenetics
    Nobuhiro Nakai
    Susumu Otsuka
    Jihwan Myung
    Toru Takumi
    Science China Life Sciences, 2015, 58 : 976 - 984
  • [47] Social anxiety in adult autism spectrum disorder
    Bejerot, Susanne
    Eriksson, Jonna M.
    Mortberg, Ewa
    PSYCHIATRY RESEARCH, 2014, 220 (1-2) : 705 - 707
  • [48] Autism spectrum disorder model mice: Focus on copy number variation and epigenetics
    Nakai, Nobuhiro
    Otsuka, Susumu
    Myung, Jihwan
    Takumi, Toru
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (10) : 976 - 984
  • [49] Autoantibody profiling of monoamine oxidase A knockout mice, an autism spectrum disorder model
    Syu, Guan-Da
    Sutandy, F. X. Reymond
    Chen, Kevin
    Cheng, Yawei
    Chen, Chien-Sheng
    Shih, Jean C.
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 107 : 193 - 200
  • [50] Autism spectrum disorder model mice: Focus on copy number variation and epigenetics
    Nobuhiro NAKAI
    Susumu OTSUKA
    Jihwan MYUNG
    Toru TAKUMI
    Science China(Life Sciences), 2015, 58 (10) : 976 - 984